Expert Outlook: Arcus Biosciences Through The Eyes Of 8 Analysts
Expert Outlook: Arcus Biosciences Through The Eyes Of 8 Analysts
专家观点：通过8位分析师的眼睛看arcus biosciences
The standing of Arcus Biosciences among financial experts...During the last three months, 8 analysts shared their evaluations of Arcus Biosciences (NYSE:RCUS), revealing diverse outlooks from bullish to bearish.
在过去的三个月里，8位分析师分享了对arcus biosciences（纽交所:RCUS）的评估，展示了从看好到看淡的多样化展望。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $25.12, with a high estimate of $30.00 and a low estimate of $20.00. Marking an increase of 1.17%, the current average surpasses the previous average price target of $24.83.
分析师对12个月价格目标的评估提供了额外的见解，展示了平均目标为25.12美元，最高估值为30.00美元，最低估值为20.00美元。当前平均水平比之前的24.83美元的平均价格目标提高了1.17%。
Breaking Down Analyst Ratings: A Detailed Examination
分析师评级分析：详细分析
The standing of Arcus Biosciences among financial experts...
通过对最近分析师...
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间